K Calleweart

No ORCID on file · 1 paper in corpus

article 2003

Endometrial safety with a low-dose intrauterine levonorgestrel-releasing system after 3 years of estrogen substitution therapy

·doi:10.1016/j.maturitas.2003.07.002

ObjectiveTo evaluate the pharmacodynamic effects of a novel intrauterine drug delivery system, FibroPlant-levonorgestrel (LNG), on the endometrium in 24 postmenopausal women using estrogen substitution therapy (EST) to suppress climacteric …